Laboratory diagnosis of antiphospholipid syndrome

Abstract Views: 774
PDF: 737
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Diagnosis of antiphosholipid syndrome (APS) is based on laboratory detection of antiphospholipid (aPL) antibodies in patients with documented thrombosis or in women with pregnancy morbidity. Recently, both clinical and laboratory criteria were revised on the basis of an international consensus conference held in Sydney (1). The previous international consensus statement of one clinical and one laboratory criterion to diagnose APS was maintained (2) but time-lapse between the previous thromboembolism and laboratory diagnosis should not exceed 5 years. Moreover, laboratory tests should not be performed in the 12 weeks following the event to avoid any interference of the acute phase of the disease. Thus, laboratory evaluation of venous thromboembolism (VTE) should not be requested during the hospital stay as tests may be false-positive with no influence on the treatment regimen...

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Pengo, V., & Ruffatti, A. (2007). Laboratory diagnosis of antiphospholipid syndrome. Reumatismo, 59(3), 187–191. https://doi.org/10.4081/reumatismo.2007.187